Item 16. Form 10-K Summary

Registrants may voluntarily include a summary of information required by Form 10-K under this Item 16. The Company has elected to not include such summary information.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SOLVENTUM CORPORATION

(Registrant)


Date: February 28, 2025
	By	/s/ Wayde McMillan
		Wayde McMillan,
	Executive Vice President and Chief Financial Officer (Mr. McMillan is the Principal Financial Officer and has been duly authorized to sign on behalf of the Registrant.)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated on February 7, 2024.


Signature						Title
/s/ Bryan Hanson						Chief Executive Officer (Principal Executive Officer and Director)
/s/ Mary Wilcox						Senior Vice President, Corporate Controller and Chief Accounting Officer (Principal Accounting Officer)
/s/Carlos Albán						Director
/s/Carrie S. Cox						Chair of the Board of Directors
/s/Susan D. DeVore						Director
/s/Shirley Edwards						Director
/s/Glenn A. Eisenberg						Director
/s/Dr. Bernard A. Harris Jr.						Director
/s/Karen J. May						Director
/s/Elizabeth A. Mily						Director
/s/John H. Weiland						Director
/s/Amy A. Wendell						Director
/s/Darryl L. Wilson						Director

Wayde McMillan, by signing his name hereto, does hereby sign this document pursuant to powers of attorney duly executed by the other persons named, filed with the Securities and Exchange Commission on behalf of such other persons, all in the capacities and on the date stated, such persons constituting a majority of the directors of the Company.


			By			/s/ Wayde McMillan
						Wayde McMillan, Attorney-in-Fact

Previous: Item 15. Exhibits, Financial Statement Schedules